Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Rituximab en el tratamiento de los linfomas cutáneos B primarios: revisión

Autor: Fernández-Guarino, M., Ortiz-Romero, P.L., Fernández-Misa, R., Montalbán, C.

Publikováno v: In Actas dermosifiliograficas June 2014 105(5):438-445

A randomized phase II study comparing consolidation with a single dose of Y-90 ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results

Autor: Lopez-Guillermo A, Canales M, Dlouhy I, Mercadal S, Briones J, Garcia-Sancho A, Sancho J, Moraleda J, Terol M, Salar A, Palomera L, Gardella S, Jarque I, Ferrer S, Bargay J, Lopez A, Panizo C, Muntanola A, Montalban C, Conde E, Hernandez M, Soler A, Marco J, Deben G, Marin J, Tomas J, PETHEMA GELTAMO GELCAB Spanish Int

Publikováno v: LEUKEMIA & LYMPHOMA
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

This is a randomized phase-2 trial aimed to compare consolidation vs. maintenance in untreated patients with follicular lymphoma (FL) responding to induction. 146 patients were enrolled from 25 Spanish institutions (ZAR2007; ClinicalTrials.gov #NCT00

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::539d628c41d3a190e087c66ea95f265b
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16278

Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial

Autor: Penalver, FJ, Marquez, JA, Duran, S, Giraldo, P, Martin, A, Montalban, C, Sancho, JM, Ramirez, MJ, Terol, MJ, Capote, FJ, Gutierrez, A, Sanchez, B, Lopez, A, Salar, A, Rodriguez-Caravaca, G, Canales, M, Caballero, MD, Lopez, JLB, Carbonell, F, Bordas, SF, Lopez, PF, Persona, EP, Guillermo, AL, Martin, RH, Mayans, JR, Palomera, L, Ceballos, EP, Hernandez, JAQ, Grau, RR, de la Cruz, F, Salinas, AS

Publikováno v: Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Cancer medicine
r-FISABIO. Repositorio Institucional de Producción Científica
Cancer Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol

Background Consensus is lacking regarding the optimal salvage therapy for patients with follicular lymphoma who relapse after or are refractory to immunochemotherapy. Methods This phase II trial evaluated the efficacy and safety of response-adapted t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::38d0108d847e62c93eac4419133d1794
http://zaguan.unizar.es/record/86474

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.